Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now Post author:Sam Post published:November 28, 2017 Post category:BioPharma Omeros is getting a lot of love from investors and analysts these days. Source: BioSpace You Might Also Like 2 Fast-Rising Biotech Stocks With No Competition in Sight July 17, 2017 Leica Microsystems Announces Collaboration With ASM International February 5, 2017 Kendall Square Upstart Comes Out of Stealth Mode With $26 Million January 23, 2017
